Long intergenic non-protein coding RNA 1036 (LINC01036)

Long intergenic non-protein coding RNA 1036 (LINC01036) is a human long intergenic non-coding RNA (lincRNA) that belongs to the broader class of lncRNAs[1]. LincRNAs are defined as transcripts longer than 200 nucleotides, not overlapping protein-coding genes, and are typically involved in gene regulation rather than coding for proteins[5]. The specific biological role of LINC01036 remains poorly characterized—there is currently limited information on its tissue specificity, function, or direct involvement in disease. LINC01036 has been referenced in at least one study of tissue pathology, but there is no evidence supporting its use as a therapeutic target (such as a receptor, enzyme, transporter, or similar druggable entity) or as a biomarker for clinical decision-making[1][4]. As is the case with many annotated lincRNAs, it may participate in fine-tuning regulation of nearby gene expression or have tissue-specific roles[5]. **Key limitations:** - LINC01036 is _not_ an established therapeutic target such as a receptor, enzyme, or transporter. - There are no known drugs, mechanisms of drug action, or safety/therapeutic concerns associated with LINC01036. - Functional characterization and clinical significance of LINC01036 are currently minimal in the literature. **In summary:** LINC01036 is a non-protein-coding RNA without evidence for direct druggability or established functional disease association, currently considered of "other/unknown" biological function with limited available information[1][5].

Other names

LINC01036